Published in Antimicrob Agents Chemother on September 01, 1978
The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol (1986) 6.00
Three decades of beta-lactamase inhibitors. Clin Microbiol Rev (2010) 5.54
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. Antimicrob Agents Chemother (1982) 3.30
Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity. Antimicrob Agents Chemother (1979) 3.27
Comparative inhibition beta-lactamases by novel beta-lactam compounds. Antimicrob Agents Chemother (1979) 2.97
Methodology for the study of beta-lactamases. Antimicrob Agents Chemother (1986) 2.82
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides. Antimicrob Agents Chemother (1980) 2.74
In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin. J Clin Invest (1986) 2.31
Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother (1982) 2.27
Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob Agents Chemother (1982) 2.12
Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination. J Clin Microbiol (1987) 1.89
Pharmacokinetics of sulbactam in humans. Antimicrob Agents Chemother (1983) 1.86
In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother (1989) 1.84
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria. Antimicrob Agents Chemother (1985) 1.77
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production. Antimicrob Agents Chemother (1982) 1.73
Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin. Antimicrob Agents Chemother (1991) 1.63
Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics. Microbiol Rev (1981) 1.58
Beta-lactamase inhibitors from laboratory to clinic. Clin Microbiol Rev (1988) 1.52
Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri. Antimicrob Agents Chemother (1980) 1.52
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012). Antimicrob Agents Chemother (2013) 1.50
Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Antimicrob Agents Chemother (1980) 1.45
Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 1.38
Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam. Antimicrob Agents Chemother (1983) 1.37
The inhibition of beta-lactamases from gram-negative bacteria by clavulanic acid. Biochem J (1981) 1.28
In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination. J Clin Microbiol (1987) 1.18
Kinetic and physical studies of beta-lactamase inhibition by a novel penem, BRL 42715. Biochem J (1994) 1.14
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks. J Clin Microbiol (1984) 1.13
Pharmacokinetics of sultamicillin in mice, rats, and dogs. Antimicrob Agents Chemother (1984) 1.09
Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination. J Clin Microbiol (1988) 1.04
Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae. Antimicrob Agents Chemother (1981) 1.04
Inhibition of class C beta-lactamases by (1'R,6R)-6-(1'-hydroxy)benzylpenicillanic acid SS-dioxide. Biochem J (1985) 1.03
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species. Antimicrob Agents Chemother (1981) 1.00
Effects of ampicillin plus sulbactam on bowel flora in patients undergoing colorectal surgery. Antimicrob Agents Chemother (1982) 0.97
Covalent binding of moxalactam to cephalosporinase of Citrobacter freundii. Antimicrob Agents Chemother (1985) 0.95
Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis. Antimicrob Agents Chemother (1989) 0.92
In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1989) 0.92
Sultamicillin in the treatment of gonorrhoea caused by penicillin sensitive and penicillinase producing strains of Neisseria gonorrhoeae. Br J Vener Dis (1983) 0.92
Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis. Antimicrob Agents Chemother (1987) 0.89
Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview. Biochem J (1993) 0.88
beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanate. Antimicrob Agents Chemother (1983) 0.88
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters. Antimicrob Agents Chemother (1990) 0.87
Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99. Antimicrob Agents Chemother (1999) 0.84
Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. Drugs (1986) 0.82
Single dose intramuscular sulbactam and ampicillin in treating acute uncomplicated gonorrhoea. Genitourin Med (1985) 0.81
Sulbactam/ampicillin versus cefotaxime as initial therapy in serious soft tissue, joint and bone infections. Drugs (1988) 0.81
A comparison of parenteral sulbactam/ampicillin versus clindamycin/gentamicin in the treatment of pelvic inflammatory disease. Drugs (1986) 0.81
Penetration of sulbactam and ampicillin into peritoneal fluid. Antimicrob Agents Chemother (1983) 0.81
Targeting Antibiotic Resistance. Angew Chem Int Ed Engl (2016) 0.79
Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid. J Clin Microbiol (1988) 0.79
Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis. Antimicrob Agents Chemother (1988) 0.79
Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery. Antimicrob Agents Chemother (1991) 0.79
Sulbactam/ampicillin in the treatment of lower respiratory infections. Drugs (1988) 0.78
Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance. Antimicrob Agents Chemother (1998) 0.78
Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase. Antimicrob Agents Chemother (1984) 0.76
Therapeutic trial and pharmacokinetics of sulbactam for uncomplicated gonorrhea in men. Antimicrob Agents Chemother (1984) 0.76
Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis. Antimicrob Agents Chemother (1985) 0.76
Chemistry of newer antibiotics directed toward overcoming bacterial resistance. Bull N Y Acad Med (1987) 0.75
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients. Korean J Intern Med (1999) 0.75
Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase. Theor Biol Med Model (2013) 0.75
Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam. Antimicrob Agents Chemother (1982) 0.75
Twenty-one years of beating beta-lactamases. Br Med J (Clin Res Ed) (1982) 0.75
Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to sheep. Can J Vet Res (1999) 0.75
Clinical and pathological evaluation of sulbactam/ampicillin for treatment of experimental bovine pneumonic pasteurellosis. Can Vet J (1988) 0.75
New sensitive bioassay for sulbactam in bovine tissues. Antimicrob Agents Chemother (1988) 0.75
In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations. Drugs (1988) 0.75
Clinical and pharmacokinetic studies of sulbactam/penicillin combinations in the treatment of ear, nose and throat infections. Drugs (1988) 0.75
The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother (1976) 18.58
Micro-iodometric assay for penicillinase. Biochem J (1962) 16.45
Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother (1977) 11.58
Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. Antimicrob Agents Chemother (Bethesda) (1968) 8.23
Naturally-occurring beta-lactamase inhibitors with antibacterial activity. J Antibiot (Tokyo) (1976) 6.48
Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol (1996) 4.86
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother (1987) 3.49
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides. Antimicrob Agents Chemother (1980) 2.74
Carbenicillin indanyl sodium, an orally active derivative of carbenicillin. Antimicrob Agents Chemother (1972) 2.17
Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J Antibiot (Tokyo) (1988) 1.78
Ultrastructure of Actinomyces viscosus and Actinomyces naeslundii. Arch Oral Biol (1974) 1.75
Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa. Antimicrob Agents Chemother (Bethesda) (1969) 1.71
Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. Rev Infect Dis (1987) 1.64
Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection. J Antimicrob Chemother (1990) 1.49
Effects of environmental factors on the in vitro potency of azithromycin. Eur J Clin Microbiol Infect Dis (1991) 1.47
Anthelmintic studies with pyrantel. I. Therapeutic and prophylactic efficacy against the enteral stages of various helminths in mice and dogs. J Parasitol (1967) 1.38
Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. J Antimicrob Chemother (1990) 1.25
Alpha-6-deoxyoxytetracycline. I. Some biological properties. Proc Soc Exp Biol Med (1966) 1.23
Properties of ribosomal binding sites for phenylalanyl-transfer ribonucleic acid. J Mol Biol (1967) 1.23
Influence of subtherapeutic levels of oxytetracycline on Salmonella typhimurium in swine, alves, and chickens. Antimicrob Agents Chemother (1975) 1.18
Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency. Antimicrob Agents Chemother (1984) 1.17
Activity of sulbactam/ampicillin in screening and discriminative animal models of infection. Rev Infect Dis (1987) 1.17
Tinidazole, a potent new antiprotozoal agent. Antimicrob Agents Chemother (Bethesda) (1969) 1.14
The site of action of a broad-spectrum aryltriazine anticoccidial, CP-25,415. J Parasitol (1974) 1.11
Pharmacokinetics of sultamicillin in mice, rats, and dogs. Antimicrob Agents Chemother (1984) 1.09
Body image across the life span in adult women: the role of self-objectification. Dev Psychol (2001) 1.09
Pirbenicillin: pharmacokinetic parameters in mice. Antimicrob Agents Chemother (1976) 1.07
Laboratory studies with a new broad-spectrum penicillin, pirbenicillin. Antimicrob Agents Chemother (1976) 1.04
Nitroimidazole derivatives. Relationship between structure and antitrichomonal activity. J Med Chem (1967) 1.04
Carbenicillin: chemistry and mode of action. J Infect Dis (1970) 1.00
Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice. J Antimicrob Chemother (1993) 0.98
Inactivation of Escherichia coli ribosomes by 1-fluoro-2,4-dinitrobenzene. J Mol Biol (1971) 0.98
Laboratory evaluation of 3-(5-tetrazolyl) penam, a new semisynthetic beta-lactam antibacterial agent with extended broad-spectrum activity. Antimicrob Agents Chemother (1976) 0.97
3-substituted nitrofurantoins as urinary-tract anti-infectives. Antimicrob Agents Chemother (Bethesda) (1966) 0.96
Activity of tetracyclines, nalidixic acids, and nitrofurantoin in two experimental models of Escherichia coli urinary tract disease in rats. Proc Soc Exp Biol Med (1971) 0.96
Preferential concentration of azithromycin in an infected mouse thigh model. J Antimicrob Chemother (1993) 0.96
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses. J Antimicrob Chemother (1993) 0.94
Reversible dissociation of Escherichia coli ribosomes by N-ethylmaleimide. Biochim Biophys Acta (1969) 0.93
Quinoxaline-1, 4-di-N oxides. I. Inhibition of deoxyribonucleic acid synthesis in Escherichia coli by 2,3-dihydroxymethyl-quinoxaline-1, 4-di-N-oxide. Proc Soc Exp Biol Med (1970) 0.90
Correlation between the binding of beta-lactam antibiotics to Staphylococcus aureus and their physical-chemical properties. Antimicrob Agents Chemother (1972) 0.89
Pirbuterol, a selecttve beta2 adrenergic bronchodilator. J Pharmacol Exp Ther (1978) 0.88
Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. J Antibiot (Tokyo) (1995) 0.87
Influence of subtherapeutic levels of a combination of neomycin and oxytetracycline on Salmonella typhimurium in swine, calves, and chickens. Antimicrob Agents Chemother (1976) 0.86
Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives. Antimicrob Agents Chemother (1984) 0.85
Novel anthelmintic agents. II. Pyrantel and other cyclic amidines. J Med Chem (1969) 0.85
Motor equivalence and self-motion induced by different movement speeds. Exp Brain Res (2011) 0.84
A comparative study of the fatty acids of some micrococci. Can J Microbiol (1971) 0.83
Fine structure and fatty acid composition of a motile streptococcus. Antonie Van Leeuwenhoek (1971) 0.83
Ultrastructure of a marine Thiobacillus. J Gen Microbiol (1974) 0.82
Apha-6-deoxyocytetracycline. 3. Total and unbound antibiotic serum concentrations after oral administration to mice. Proc Soc Exp Biol Med (1967) 0.82
Fine structure of resting and germinating Penicillium chrysogenum conidiospores. Protoplasma (1971) 0.81
Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antimicrob Agents Chemother (1991) 0.81
Alkylation of 2-methyl-5-nitroimidazole. Some potent antiprotozoal agents. J Med Chem (1970) 0.80
Cephalosporins to carbapenems: 1-oxygenated carbapenems and carbapenams. J Med Chem (1990) 0.80
Alpha-6-deoxyoxytetracycline. II. Activity in chemotherapeutic studies in the mouse. Proc Soc Exp Biol Med (1967) 0.80
Consumer selection of physicians and dentists: an examination of choice criteria and cue usage. J Health Care Mark (1988) 0.79
Beta-aminoketones as anti-infective agents. Antimicrob Agents Chemother (Bethesda) (1965) 0.79
Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin. Eur J Clin Microbiol Infect Dis (1991) 0.79
Novel anthelmintic agents. V. Thiazoline and dihydrothiazine analogs of pyrantel. J Med Chem (1970) 0.78
Side chain modifications in lankacidin group antibiotics. Antimicrob Agents Chemother (1984) 0.77
In vitro microbiological characterization of novel cyclic homopentapeptides, CP-101,680 and CP-163,234, for animal health use. J Antibiot (Tokyo) (1999) 0.77
Structure-activity relationships of 6-(heterocyclyl)-methylene penam sulfones; a new class of beta-lactamase inhibitors. J Antibiot (Tokyo) (1987) 0.77
Pyelonephritis in the mouse. II. Vaccination studies. Proc Soc Exp Biol Med (1968) 0.76
New sensitive bioassay for sulbactam in bovine tissues. Antimicrob Agents Chemother (1988) 0.75
Pyrantel tartrate, a new anthelmintic effective against infections of domestic animals. Nature (1966) 0.75
(6R,8S)-(2-benzimidazolyl)hydroxymethylpenicillanic acids as potent antibacterial agents and beta-lactamase inhibitors. J Antibiot (Tokyo) (1991) 0.75
Preliminary Report on the Circumpolar Distribution of Neoechinorhynchus rutili (Acanthocephala) in Fresh Water Fishes. Science (1949) 0.75
Alpha-6-deoxyoxytetracycline IV. Penetration and concentration within a localized area of inflammation. Proc Soc Exp Biol Med (1968) 0.75
In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use. J Antibiot (Tokyo) (1998) 0.75
A comparison of the fine structure of Micrococcus diversus, Neisseria catarrhalis and Neisseria sicca. Antonie Van Leeuwenhoek (1970) 0.75
[Polyacrylic bone cement with added erythromycin and colistin. In vitro studies on bacteriologic activity and diffusion properties]. MMW Munch Med Wochenschr (1976) 0.75
Current experiences in testing of Pseudomonas for susceptibility to carbenicillin. J Infect Dis (1973) 0.75
Indanyl carbenicillin: chemistry and laboratory studies with a new semisynthetic penicillin. J Infect Dis (1973) 0.75
Anticoccidial derivatives of 6-azauracil. 5. Potentiation by benzophenone side chains. J Med Chem (1983) 0.75
Discovery of the hemifumarate and (alpha-L-alanyloxy)methyl ether as prodrugs of an antirheumatic oxindole: prodrugs for the enolic OH group. J Med Chem (1996) 0.75
Ring contraction of oleandrose on the macrolide antibiotic oleandomycin with [(Methoxycarbonyl)sulfamoyl]triethylammonium hydroxide inner salt. J Med Chem (1982) 0.75
A nutritional study of some agarolytic marine bacteria. Can J Microbiol (1968) 0.75
Activity of 6-methylene oxytetracycline in localized infections in mice. Antimicrob Agents Chemother (Bethesda) (1965) 0.75
Synthesis and beta-lactamase inhibitory activity of thiazolyl penam sulfones. J Antibiot (Tokyo) (1988) 0.75
Effects of extended aging and modified atmospheric packaging on beef top loin steak color. J Anim Sci (2016) 0.75
Influence of immunosuppression on the pharmacokinetics and pharmacodynamics of azithromycin in infected mouse tissues. J Antimicrob Chemother (1996) 0.75